Trends of early-onset colorectal cancer biomarkers from 1985 to 2024 : a bibliometric analysis

Article Sidebar

PDF
Published: 2026-06-08
DOI: https://doi.org/10.18051/UnivMed.2026.v45.%25p
Keywords:
Colorectal Cancer, Biomarker, Bibliometric analysis, Digestive surgery

Main Article Content

Hamzah Haryo Prakoso
Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia
https://orcid.org/0009-0007-0389-4985
Andre Setiawan
Department of Biomedical Laboratory, Faculty of Medicine, Universitas Sebelas Maret, Surakarta, Indonesia
https://orcid.org/0009-0004-9370-7685
Nur Rahadiani
Department of Pathological Anatomy, Faculty of Medicine-University of Indonesia, Dr. Cipto Mangunkusumo National Hospital, Jakarta, Indonesia
https://orcid.org/0000-0003-2342-8133

Abstract

Early-onset colorectal cancer (EOCRC) is increasingly recognized as a global public health concern. Biomarker research in EOCRC has expanded across hereditary, molecular, epigenetic, liquid biopsy, microbiome, and multi-omics domains, but the overall research landscape remains fragmented. This study aimed to map global research trends and identify prominent and underdeveloped topics in EOCRC biomarker research. A bibliometric analysis was conducted using publications on EOCRC biomarkers retrieved on October 27, 2024. Eligible documents were limited to English-language articles, reviews, and conference proceedings, with a final publication stage and no restriction on publication year. After screening, 134 relevant documents published between 1985 and 2024 were included. Bibliometric indicators, including publication trends, leading contributors, influential publications, topic evolution, and keyword co-occurrence patterns, were analyzed using Biblioshiny (Bibliometrix R package v4.1.3) and VOS viewer (v1.6.18). Early-onset colorectal cancer  biomarker research showed steady growth, with an annual growth rate of 7.54% and a publication peak in 2023. The dataset included 134 documents from 92 sources and involved 1,121 authors, with international collaboration observed in 20.9% of publications. Earlier studies focused mainly on hereditary predisposition, Lynch syndrome, mismatch repair genes, and microsatellite instability. More recent research shifted toward molecular profiling, epigenetic alterations, liquid biopsy, gut microbiota, tumor microenvironment, and multi-omics approaches. Underdeveloped areas included diagnostic biomarker validation, screening implementation, gut microbiota, risk factors, and machine learning-based biomarker discovery. Overall, EOCRC biomarker research has evolved from a hereditary-centered focus toward a broader precision oncology framework, but further work is needed to strengthen validation, translational relevance, and clinical applicability across diverse populations.

Article Details

Issue

Vol. 45 No. 2 (2026): Ahead Of Print

Section

Review Article
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The journal allows the authors to hold the copyright without restrictions and allow the authors to retain publishing rights without restrictions.

How to Cite

Trends of early-onset colorectal cancer biomarkers from 1985 to 2024 : a bibliometric analysis. (2026). Universa Medicina, 45(2). https://doi.org/10.18051/UnivMed.2026.v45.%p

References

1. Cohen D, Rogers C, Gabre J, Dionigi B. The young: early-onset colon cancer. Clin Colon Rectal Surg 2025;38:173–8. doi: 10.1055/s-0044-1787883.

2. Dwyer AJ, Rathod A, King C, et al. Advancing early onset colorectal cancer research: research advocacy, health disparities, and scientific imperatives. Front Oncol 2024;14: 1394046. doi: 10.3389/fonc.2024.1394046.

3. Tsokkou S, Konstantinidis I, Chatzikomnitsa P, et al. The molecular signature of early-onset colorectal cancer liver metastases: distinct biology and clinical challenges. Int J Mol Sci 2026;27:3289. doi: 10.3390/ijms27073289.

4. Liao C-K, Hsu Y-J, Chern Y-J, et al. Differences in characteristics and outcomes between early-onset colorectal cancer and late-onset colorectal cancers. Eur J Surg Oncol 2024;50:108687. doi: 10.1016/j.ejso.2024.108687.

5. Chen SL, Xin JY, Du ML, Wang ML. [Multi-omics research progress in early-onset colorectal cancer]. Zhonghua Wei Chang Wai Ke Za Zhi 2024;27:447–51. Chinese. doi: 10.3760/cma.j.cn441530-20240205-00058.

6. Drăgan LȘ, Gheorghe C. Lynch syndrome: approach from the gastroenterologist’s point of view. Rom J Mil Med 2023;126:35–41. doi: 10.55453/rjmm.2023.126.5.4.

7. Aoun RJN, Kalady MF. Hereditary colorectal cancer: from diagnosis to surgical options. Clin Colon Rectal Surg 2025;38:179–90. doi: 10.1055/s-0044-1787884.

8. Ditonno I, Novielli D, Celiberto F, et al. Molecular pathways of carcinogenesis in familial adenomatous polyposis. Int J Mol Sci 2023;24:5687. doi: 10.3390/ijms24065687.

9. Hamilton AC, Bannon FJ, Dunne PD, et al. Distinct molecular profiles of sporadic early-onset colorectal cancer: a population-based cohort and systematic review. Gastro Hep Advances 2023;2:347–59. doi: 10.1016/j.gastha.2022.11.005.

10. Islam MR, Arthur S, Haynes J, Butts MR, Nepal N, Sundaram U. The role of gut microbiota and metabolites in obesity-associated chronic gastrointestinal disorders. Nutrients 2022;14:624. doi: 10.3390/nu14030624.

11. Singh S, Sharma P, Sarma D, et al. Implication of obesity and gut microbiome dysbiosis in the etiology of colorectal cancer. Cancers (Basel) 2023;15:1913. doi: 10.3390/cancers15061913.

12. Hashmi AA, Aslam M, Rashid K, et al. Early-onset/young-onset colorectal carcinoma: a comparative analysis of morphological features and biomarker profile. Cureus 2023;15: :e42340. doi: 10.7759/cureus.42340.

13. Das S, Dey MK, Devireddy R, Gartia MR. Biomarkers in cancer detection, diagnosis, and prognosis. Sensors 2023;24:37. doi: 10.3390/s24010037.

14. Lawler T, Parlato L, Warren Andersen S. The histological and molecular characteristics of early-onset colorectal cancer: a systematic review and meta-analysis. Front Oncol 2024; 14:1349572. doi: 10.3389/fonc.2024.1349572.

15. Aghagolzadeh P, Radpour R. New trends in molecular and cellular biomarker discovery for colorectal cancer. World J Gastroenterol 2016;22:5678. doi: 10.3748/wjg.v22.i25.5678.

16. Lișcu H-D, Verga N, Atasiei D-I, et al. Biomarkers in colorectal cancer: actual and future perspectives. Int J Mol Sci 2024;25:11535. doi: 10.3390/ijms252111535.

17. Chen C, Song M. Visualizing a field of research: a methodology of systematic scientometric reviews. PLoS One 2019;14:e0223994. doi: 10.1371/journal.pone.0223994.

18. Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res 2021;133:285–96. doi: 10.1016/j.jbusres.2021.04.070.

19. Zhang M, Zhu S, Chen L, et al. Knowledge mapping of early-onset colorectal cancer from 2000 to 2022: A bibliometric analysis. Heliyon 2023;9:e18499. doi: 10.1016/j.heliyon.2023.e18499.

20. van Eck NJ, Waltman L. Citation-based clustering of publications using CitNetExplorer and VOSviewer. Scientometrics 2017;111:1053–70. doi: 10.1007/s11192-017-2300-7.

21. Aria M, Cuccurullo C. bibliometrix : An R-tool for comprehensive science mapping analysis. J Informetr 2017;11:959–75. doi: 10.1016/j.joi.2017.08.007.

22. Ilyas MF, Lukas GA, Lado A, et al. A bibliometric study of worldwide scientific literature on somatopsychics (1913‒2022). Bratisl Lek Listy 2024;125:441–9. doi: 10.4149/BLL_2024_68.

23. Nakamura K, Hernández G, Sharma GG, et al. A liquid biopsy signature for the detection of patients with early-onset colorectal cancer. Gastroenterology 2022;163:1242-51.e2. doi: 10.1053/j.gastro.2022.06.089.

24. Sinicrope FA. Increasing incidence of early-onset colorectal cancer. N Engl J Med 2022;386:1547–58. doi: 10.1056/NEJMra2200869.

25. McClelland PH, Liu T, Ozuner G. Early-onset colorectal cancer in patients under 50 years of age: demographics, disease characteristics, and survival. Clin Colorectal Cancer 2022;21:e135–44. doi: 10.1016/j.clcc.2021.11.003.

26. Saraiva MR, Rosa I, Claro I. Early-onset colorectal cancer: a review of current knowledge. World J Gastroenterol 2023;29:1289–303. doi: 10.3748/wjg.v29.i8.1289.

27. Fritz CDL, Otegbeye EE, Zong X, et al. Red-flag signs and symptoms for earlier diagnosis of early-onset colorectal cancer. J Natl Cancer Inst 2023;115:909–16. doi: 10.1093/jnci/djad068.

28. Nfonsam V, Wusterbarth E, Gong A, Vij P. Early-onset colorectal cancer. Surg Oncol Clin N Am 2022;31:143–55. doi: 10.1016/j.soc.2021.11.001.

29. O’Sullivan DE, Ruan Y, Cheung WY, et al. Early-onset colorectal cancer incidence, staging, and mortality in Canada: implications for population-based screening. Am J Gastroenterol 2022;117:1502–7. doi: 10.14309/ajg.0000000000001884.

30. Niedermaier T, Tikk K, Gies A, Bieck S, Brenner H. Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location. Clin Gastroenterol Hepatol 2020;18:2920-8.e6. doi: 10.1016/j.cgh.2020.01.025.

31. Keenan JI, Frizelle FA. Biomarkers to detect early-stage colorectal cancer. Biomedicines 2022;10:255. doi: 10.3390/biomedicines10020255.

32. Ullah F, Pillai AB, Omar N, Dima D, Harichand S. Early-onset colorectal cancer: current insights. Cancers (Basel) 2023;15:3202. doi: 10.3390/cancers15123202.

33. Danese E, Montagnana M, Lippi G. Circulating molecular biomarkers for screening or early diagnosis of colorectal cancer: which is ready for prime time? Ann Transl Med 2019;7:610–610. doi: 10.21037/atm.2019.08.97.

34. AlZaabi A, Shalaby A. A systematic review of diagnostic performance of circulating microRNAs in colorectal cancer detection with a focus on early-onset colorectal cancer. Int J Mol Sci 2024;25:9565. doi: 10.3390/ijms25179565.

35. Loomans-Kropp HA, Song Y, Gala M, et al. Methylated septin9 (m SEPT9): a promising blood-based biomarker for the detection and screening of early-onset colorectal cancer. Cancer Res Commun 2022;2:90–8. doi: 10.1158/2767-9764.CRC-21-0142.

36. Bresalier RS, Grady WM, Markowitz SD, Nielsen HJ, Batra SK, Lampe PD. Biomarkers for early detection of colorectal cancer: the early detection research network, a framework for clinical translation. Cancer Epidemiol Biomarkers Prev 2020;29:2431–40. doi: 10.1158/1055-9965.EPI-20-0234.

37. Ho V, Chung L, Wilkinson K, et al. Microsatellite instability testing and prognostic implications in colorectal cancer. Cancers (Basel) 2024;16:2005. doi: 10.3390/cancers16112005.

38. Willauer AN, Liu Y, Pereira AAL, et al. Clinical and molecular characterization of early‐onset colorectal cancer. Cancer 2019;125:2002–10. doi: 10.1002/cncr.31994.

39. Lauricella S, Brucchi F, Cirocchi R, Cassini D, Vitellaro M. The gut microbiome in early-onset colorectal cancer: distinct signatures, targeted prevention and therapeutic strategies. J Pers Med 2025;15:552. doi: 10.3390/jpm15110552.

40. Zwezerijnen-Jiwa FH, Sivov H, Paizs P, Zafeiropoulou K, Kinross J. A systematic review of microbiome-derived biomarkers for early colorectal cancer detection. Neoplasia 2023;36:100868. doi: 10.1016/j.neo.2022.100868.

41. Abdullah M, Sukartini N, Nursyirwan SA, et al. Gut microbiota profiles in early- and late-onset colorectal cancer: a potential diagnostic biomarker in the future. Digestion 2021;102:823–32. doi: 10.1159/000516689.

42. Zackular JP, Rogers MAM, Ruffin MT, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res 2014;7:1112–21. doi: 10.1158/1940-6207.CAPR-14-0129.

43. Wu Y, Jiao N, Zhu R, et al. Identification of microbial markers across populations in early detection of colorectal cancer. Nat Commun 2021;12:3063. doi: 10.1038/s41467-021-23265-y.

44. Li N, He H. Topic evolution analysis for omics data integration in cancers. Front Cell Dev Biol 2021;9. doi: 10.3389/fcell.2021.631011.

45. Ganesh K, Stadler ZK, Cercek A, et al. Immunotherapy in colorectal cancer: rationale, challenges and potential. Nat Rev Gastroenterol Hepatol 2019;16:361–75. doi: 10.1038/s41575-019-0126-x.

46. Jacobs D, Zhu R, Luo J, et al. Defining early-onset colon and rectal cancers. Front Oncol 2018;8:504. doi: 10.3389/fonc.2018.00504.

47. Alshenaifi JY, Maddalena G, Lal JC, et al. proteotranscriptomic analyses of microsatellite-stable early-onset colorectal cancer. JCO Oncol Adv 2025;2:e2400090. doi: 10.1200/OA-24-00090.

48. Du M, Gu D, Xin J, et al. Integrated multi-omics approach to distinct molecular characterization and classification of early-onset colorectal cancer. Cell Rep Med 2023;4:100974. doi: 10.1016/j.xcrm.2023.100974.

49. Hua H, Wang T, Pan L, et al. A proteomic classifier panel for early screening of colorectal cancer: a case control study. J Transl Med 2024;22:188. doi: 10.1186/s12967-024-04983-5.

50. Gold A, Choueiry F, Jin N, Mo X, Zhu J. The application of metabolomics in recent colorectal cancer Studies: a state-of-the-art review. Cancers (Basel) 2022;14:725. doi: 10.3390/cancers14030725.

51. Purnomo H, Handaya Y, Setyawan N. Neutrophil to hemoglobin lymphocyte ratio (NHLR) as a novel biomarker is superior to neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR) as predictors of advanced colorectal cancer. Indones J Cancer 2024;18:47–52. doi: 10.33371/ijoc.v18i1.1099.

52. Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average‐risk screening. Cancer 2016;122:929–34. doi: 10.1002/cncr.29716.

53. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non–polyposis colorectal cancer patients. Nat Med 1996;2:169–74. doi: 10.1038/nm0296-169.

54. Mauri G, Sartore‐Bianchi A, Russo A, Marsoni S, Bardelli A, Siena S. Early‐onset colorectal cancer in young individuals. Mol Oncol 2019;13:109–31. doi: 10.1002/1878-0261.12417.

55. Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer — a call to action. Nat Rev Clin Oncol 2021;18:230–43. doi: 10.1038/s41571-020-00445-1.

56. Lynch HT, Kimberling W, Albano WA, et al. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource. Cancer 1985;56:934–8. doi: 10.1002/1097-0142(19850815)56:4<934::AID-CNCR2820560439>3.0.CO;2-I.

57. Southey MC, Jenkins MA, Mead L, et al. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 2005;23:6524–32. doi: 10.1200/JCO.2005.04.671.

58. Abdel-Rahman SZ, Soliman AS, Bondy ML, et al. Inheritance of the 194Trp and the 399Gln variant alleles of the DNA repair gene XRCC1 are associated with increased risk of early-onset colorectal carcinoma in Egypt. Cancer Lett 2000;159:79–86. doi: 10.1016/S0304-3835(00)00537-1.

59. Antelo M, Balaguer F, Shia J, et al. A high degree of LINE-1 hypomethylation Is a unique feature of early-onset colorectal cancer. PLoS One 2012;7:e45357. doi: 10.1371/journal.pone.0045357.

60. Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An update on the epidemiology, molecular characterization, diagnosis, and screening strategies for early-onset colorectal cancer. Gastroenterology 2021;160:1041–9. doi: 10.1053/j.gastro.2020.12.068.

61. Yantiss RK, Goodarzi M, Zhou XK, et al. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol 2009;33:572–82. doi: 10.1097/PAS.0b013e31818afd6b.